Literature DB >> 11922913

Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein.

Mark A Vickers1, Fiona R Green, Catherine Terry, Bongani M Mayosi, Cecile Julier, Mark Lathrop, Peter J Ratcliffe, Hugh C Watkins, Bernard Keavney.   

Abstract

OBJECTIVE: Baseline concentrations of plasma C-reactive protein (CRP) are associated with coronary heart disease. Interleukin-6 (IL-6) regulates CRP gene expression; a promoter polymorphism (-174G/C) of the IL-6 gene has been shown to influence IL-6 transcription but the relationship between genotype at this polymorphism and circulating levels of inflammatory markers remains unclear. We hypothesised that plasma CRP would be a heritable phenotype that would be influenced by genotype at this polymorphism.
METHODS: We measured baseline plasma CRP and determined genotypes at the -174G/C polymorphism of the IL-6 gene in 588 members of 98 nuclear families. The heritability of plasma CRP and the association of plasma CRP with genotype were determined using variance components methods.
RESULTS: Baseline CRP levels were highly heritable (h(2)=0.39, P<0.0000001). Presence of the -174C allele was associated with higher baseline CRP levels, both in the whole population (P=0.01), and in the founders only (n=128, P=0.001). Family-based analyses confirmed the association (P=0.02) suggesting that it arises from chromosomal proximity or identity of the typed polymorphism with a genetic variant influencing baseline CRP levels.
CONCLUSIONS: Baseline plasma CRP is a significantly heritable cardiovascular risk factor. Levels are associated with genotype at the -174G/C polymorphism of the IL-6 gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922913     DOI: 10.1016/s0008-6363(01)00534-x

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  61 in total

Review 1.  Critical review of unstable angina and non-ST elevation myocardial infarction.

Authors:  P J Sheridan; D C Crossman
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

2.  The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers.

Authors:  J R Ortlepp; J Metrikat; K Vesper; V Mevissen; F Schmitz; M Albrecht; P Maya-Pelzer; P Hanrath; C Weber; K Zerres; R Hoffmann
Journal:  J Mol Med (Berl)       Date:  2003-08-20       Impact factor: 4.599

3.  Interleukin 6 G-174 C polymorphism and breast cancer risk.

Authors:  A M González-Zuloeta Ladd; A Arias Vásquez; J Witteman; A G Uitterlinden; J W Coebergh; A Hofman; B H Ch Stricker; C M van Duijn
Journal:  Eur J Epidemiol       Date:  2006-05-23       Impact factor: 8.082

Review 4.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

5.  Variants in C-reactive protein and IL-6 genes and susceptibility to obstructive sleep apnea in children: a candidate-gene association study in European American and Southeast European populations.

Authors:  Athanasios G Kaditis; David Gozal; Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Oscar Sans Capdevila; Konstantinos Gourgoulianis; Emmanouel I Alexopoulos; Konstantinos Chaidas; Rakesh Bhattacharjee; Jinkwan Kim; Paraskevi Rodopoulou; Elias Zintzaras
Journal:  Sleep Med       Date:  2013-12-04       Impact factor: 3.492

Review 6.  Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation.

Authors:  François Cambien
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

7.  Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population.

Authors:  Yasuaki Saijo; Megumi Utsugi; Eiji Yoshioka; Tomonori Fukui; Fumihiro Sata; Naoki Nakagawa; Naoyuki Hasebe; Takahiko Yoshida; Reiko Kishi
Journal:  Environ Health Prev Med       Date:  2009-03-17       Impact factor: 3.674

8.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

Review 9.  Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents.

Authors:  Jian Shen; Jose M Ordovas
Journal:  Clin Chem       Date:  2008-12-12       Impact factor: 8.327

Review 10.  C-reactive protein: the pawn has been promoted to queen.

Authors:  Edward T H Yeh; Robert P Palusinski
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.